Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B

BACKGROUND AND OBJECTIVES: Hsa-miR-429 is increased in bladder cancer. Its roles in bladder cancer are poorly understood. METHODS: The expression levels of hsa-miR-429 and cyclin-dependent kinase inhibitor 2B (CDKN2B) were determined using Real-Time qPCR in a total of 50 patients with bladder cancer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Yang, Jiangeng, Liu, Yuchen, He, Anbang, Liu, Yuhan, Wu, Jianting, Liao, Xinhui, Lv, Zhaojie, Wang, Feng, Mei, Hongbing
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620291/
https://ncbi.nlm.nih.gov/pubmed/28978151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19878
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares